| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/2013 | CN103260608A Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
| 08/21/2013 | CN103260606A Compositions and methods for cardiac therapy |
| 08/21/2013 | CN103255206A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 08/21/2013 | CN103255151A Coded sequence CVN (Cyanovirin-N) mutant with high expression quantity and high activity and application of coded sequence |
| 08/21/2013 | CN103255113A Cyanea capillata peroxide reductase as well as encoding gene and application thereof |
| 08/21/2013 | CN103254317A Anti-CD20 monoclonal antibody-aplysiatoxin conjugate as well as preparation method and application thereof |
| 08/21/2013 | CN103254316A Antimicrobial peptide with drug-resistance bacteria resistance activity and synthesis and application thereof |
| 08/21/2013 | CN103254315A Recombinant TAT-MANF (trans-activator of transcription-mesencephalic astrocyte derived neurotrophic factor) fusion protein and application thereof |
| 08/21/2013 | CN103254303A Preparation method and application of antineoplastic active polypeptide component in Arca subcrenata Lischke |
| 08/21/2013 | CN103254302A Method for separation of antitumor polypeptide compound from Arca subcrenata Lischke and application |
| 08/21/2013 | CN103254296A Protein AGGF1 and application of FHA polypeptide of protein AGGF1 in preparation of anti-inflammatory drug |
| 08/21/2013 | CN103254292A Tyrosine kinase tyrosine polypeptideinhibitor of vascular endothelial growth factor receptor 2 and application thereof |
| 08/21/2013 | CN103254291A Tumor necrosis factor-alpha polypeptide inhibitors and application thereof |
| 08/21/2013 | CN103254290A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 08/21/2013 | CN103254289A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254288A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254287A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254286A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254285A VEGFR2 tyrosine kinase inhibitor polypeptide and application thereof |
| 08/21/2013 | CN103254284A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254283A Tubulin polymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254282A Tubulin depolymerizing agent polypeptides 5 and application thereof |
| 08/21/2013 | CN103254281A Tubulin polymerizing agent polypeptides 6 and application thereof |
| 08/21/2013 | CN103251958A Applications of MEN1 gene and encoding protein thereof |
| 08/21/2013 | CN103251957A Treatment of spinal cord injury by transplanting stem cells modified by neurotrophic factor gene |
| 08/21/2013 | CN103251952A Genetic products differentially expressed in tumors and use thereof |
| 08/21/2013 | CN103251951A Application of P2X2 receptor agonist or opening agent in preparation of anti-depression or anti-anxiety drugs |
| 08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 08/21/2013 | CN103251937A Medicaments and methods for treating headache |
| 08/21/2013 | CN103251936A Oxygen carrier based on hemoglobin-haptoglobin compound and preparation method of oxygen carrier |
| 08/21/2013 | CN103251935A Medicinal composite containing cornu cervi pantotrichum and application thereof |
| 08/21/2013 | CN103251934A Production process of sheep and goat steroid hormone antigen twins vaccine |
| 08/21/2013 | CN103251933A Composition and methods for stimulating gastrointestinal motility |
| 08/21/2013 | CN103251932A Application of hepcidin in preparation of medicine for treating iron-associated neurodegenerative diseases |
| 08/21/2013 | CN103251931A Application of Cyr61 in psoriasis medicine |
| 08/21/2013 | CN103251930A Nano-selenium and germanium vitamin pine tree-series multi-penis and testis medicinal liquor with functions of strengthening body and tonifying yang |
| 08/21/2013 | CN103251929A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 08/21/2013 | CN103251928A Anti-hypertensive agent |
| 08/21/2013 | CN103251927A Composition containing bilberry extract |
| 08/21/2013 | CN103251926A Traditional Chinese medicine leech extract product and its application |
| 08/21/2013 | CN103251671A Traditional Chinese medicine containing composition for increasing bone mineral density and preparation method thereof |
| 08/21/2013 | CN103251647A Methods for treating bleeding disorders using sulfated polysaccharides |
| 08/21/2013 | CN102813637B Kallidinogenase enteric coated tablet and preparation method thereof |
| 08/21/2013 | CN102603887B IL-24 (interleukin-24) polypeptide with tumor resistance and application thereof |
| 08/21/2013 | CN102600067B Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel in preparing postoperation scar inhibitor |
| 08/21/2013 | CN102274493B Bleeding-stopping, inflammation-diminishing and pain-relieving nano emulsion for use in minimally invasive beauty treatment therapy and preparation method thereof |
| 08/21/2013 | CN102260320B Compound with antitumor activity and preparation method thereof |
| 08/21/2013 | CN102183665B Method and apparatus for monitoring anti-platelet agents |
| 08/21/2013 | CN102167747B Entamoeba histolytica galactose/acetylgalactosamine (Gal/GalNAc) polypeptide fragment, and preparing method and application of polypeptide fragment |
| 08/21/2013 | CN102114000B Co-feeding lipid nano-delivery system for medicine carrying |
| 08/21/2013 | CN102088975B Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use |
| 08/21/2013 | CN102026647B Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 08/21/2013 | CN101970670B Methods for inhibiting angiogenesis using egfl8 antagonists |
| 08/21/2013 | CN101856363B Application of Bortezomib in preparing drugs for curing POEMS syndrome |
| 08/21/2013 | CN101780268B Method and reagent for diagnosing, preventing and treating insulin resistance |
| 08/21/2013 | CN101511181B Proteins, nucleic acids encoding the same and associated methods of use |
| 08/21/2013 | CN101505784B Cyclic natriuretic peptide constructs |
| 08/21/2013 | CN101437532B Phage derived antimicrobial activities |
| 08/21/2013 | CN101304758B Recombinant interferon Alpha2 (IFNAlpha2) mutants |
| 08/20/2013 | US8513400 Modulation of HIF1α and HIF2α expression |
| 08/20/2013 | US8513396 Peptides and related molecules that modulate nerve growth factor activity |
| 08/20/2013 | US8513390 Modified antibody compositions, methods of making and using thereof |
| 08/20/2013 | US8513386 FVIII-independent FIX-mutant proteins for hemophilia a treatment |
| 08/20/2013 | US8513384 Selective extraction of proteins from saltwater algae |
| 08/20/2013 | US8513383 Selective extraction of proteins from saltwater algae |
| 08/20/2013 | US8513381 Melanocortin analogs with antimicrobial activity |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513201 Modified chaperonin 10 |
| 08/20/2013 | US8513200 Process for relaxing or straightening hair, using weak dicarboxylic acids with heat |
| 08/20/2013 | US8513198 Pharmaceutical formulation for reducing pain |
| 08/20/2013 | US8513197 Ganglioside epitopes for treating Guillain-Barre syndrome |
| 08/20/2013 | US8513196 Treatment of T-cell mediated diseases |
| 08/20/2013 | US8513195 Treatment of mood and anxiety disorders |
| 08/20/2013 | US8513194 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 08/20/2013 | US8513193 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 08/20/2013 | US8513192 Stable growth hormone compounds resistant to proteolytic degradation |
| 08/20/2013 | US8513191 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
| 08/20/2013 | US8513190 Method of regulating glucose metabolism, and reagents related thereto |
| 08/20/2013 | US8513189 Albumin fusion proteins |
| 08/20/2013 | US8513188 Formulations comprising cyclic compounds |
| 08/20/2013 | US8513187 Soft protease inhibitors, and pro-soft forms thereof |
| 08/20/2013 | US8513186 Antiviral compounds |
| 08/20/2013 | US8513185 Inhibition of TREM receptor signaling with peptide variants |
| 08/20/2013 | US8513184 Macrocyclic inhibitors of flaviviridae viruses |
| 08/20/2013 | US8513183 Peptide pharmaceutical for oral delivery |
| 08/20/2013 | US8513181 Substances and compositions for enhancing DNA repair and methods of use |
| 08/20/2013 | US8512984 Non-cytotoxic protein conjugates |
| 08/20/2013 | US8512962 Kit and method for detecting bovine viral diarrhea virus in tissue samples |
| 08/20/2013 | US8512932 Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 08/20/2013 | US8512740 Fibrin foam and process for making |
| 08/20/2013 | US8512737 Embolic delivery of therapeutic agents |
| 08/20/2013 | US8512731 Antimicrobial coatings for medical devices and methods for making and using them |
| 08/20/2013 | US8512716 Diagnostic, predictive and prognostic testing for cancer |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | US8512709 Modified amyloid β peptide |
| 08/20/2013 | US8512692 Methods of treating multiple sclerosis with stable liquid interferon-beta formulations |
| 08/20/2013 | US8512691 Stable liquid interferon-beta formulations |
| 08/20/2013 | CA2641310C Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/20/2013 | CA2620125C Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/20/2013 | CA2560891C Vaccine composition comprising a class ii cmh ligand coupled with an antigen, method for the preparation and the use thereof |